Search Orphan Drug Designations and Approvals
-
Generic Name: | nolatrexed |
---|---|
Date Designated: | 10/18/2001 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EXIMIAS Pharmaceutical Corporation 1055 Westlakes Drive Suite 200 Berwyn, Pennsylvania 19312 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-